• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定为患有慢性病的老年人实施和运营远程患者监测计划的成本:系统评价经济评估。

Determining the cost of implementing and operating a remote patient monitoring programme for the elderly with chronic conditions: A systematic review of economic evaluations.

机构信息

1 Faculty of Medicine, McGill University, Canada.

2 Ingram School of Nursing, McGill University, Canada.

出版信息

J Telemed Telecare. 2018 Jan;24(1):13-21. doi: 10.1177/1357633X16669239. Epub 2016 Sep 19.

DOI:10.1177/1357633X16669239
PMID:27650163
Abstract

Introduction Remote patient monitoring (RPM) in conjunction with home nursing visits is becoming increasingly popular for the follow-up of patients with chronic conditions and evidence exists that it improves patients' health outcomes. Current cost data is reported inconsistently and often gathered from studies of poor methodological quality, making it difficult for decision-makers who consider implementing this service in their organizations. This study reviewed the cost of RPM programmes targeting elderly patients with chronic conditions. Methods After evaluation against the inclusion and exclusion criteria and appraisal against two criteria which are important for economic evaluations, data from selected studies were extracted and grouped into meaningful cost categories, then adjusted to reflect November 2015 US dollars. Results In the 13 selected studies, the newly-created cost category 'Combined intervention cost' (reflecting equipment purchasing, servicing and monitoring cost) for the various RPM programmes ranged from US$275-US$7963 per patient per year. The three main findings are: (a) RPM programme costs have decreased since 2004 due to cheaper technology; (b) monitoring a single vital sign is likely to be less costly than monitoring multiple vital signs; and (c) programmes targeting hypertension or congestive heart failure are less costly than those targeting respiratory diseases or multiple conditions. Conclusions This review recommends that future studies present their cost data with more granularity, that grouping of costs should be minimized and that any assumptions, such as amortization, should be made explicit. In addition, studies should compare programmes with similar characteristics in terms of type of conditions, number of vital signs monitored, etc. for more generalizable results.

摘要

介绍 远程患者监测 (RPM) 与家庭护理访问相结合,越来越受到慢性病患者随访的欢迎,有证据表明它可以改善患者的健康结果。目前的成本数据报告不一致,并且经常来自方法学质量较差的研究,这使得考虑在其组织中实施此服务的决策者感到困难。本研究回顾了针对慢性病老年患者的 RPM 计划的成本。

方法 根据纳入和排除标准进行评估,并根据对经济评估很重要的两个标准进行评估,从选定的研究中提取数据并分为有意义的成本类别,然后调整为反映 2015 年 11 月的美元。

结果 在 13 项选定的研究中,各种 RPM 计划的新创建的成本类别“综合干预成本”(反映设备采购、维护和监测成本)为每位患者每年 275-7963 美元。主要发现有三点:(a)由于技术更便宜,自 2004 年以来 RPM 计划的成本有所降低;(b)监测单个生命体征的成本可能低于监测多个生命体征的成本;(c)针对高血压或充血性心力衰竭的计划比针对呼吸道疾病或多种疾病的计划成本更低。

结论 本综述建议未来的研究更详细地报告其成本数据,应尽量减少成本分组,并明确任何假设,如摊销。此外,研究应根据所监测的病症类型、生命体征数量等方面的相似特征来比较计划,以获得更具普遍性的结果。

相似文献

1
Determining the cost of implementing and operating a remote patient monitoring programme for the elderly with chronic conditions: A systematic review of economic evaluations.确定为患有慢性病的老年人实施和运营远程患者监测计划的成本:系统评价经济评估。
J Telemed Telecare. 2018 Jan;24(1):13-21. doi: 10.1177/1357633X16669239. Epub 2016 Sep 19.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
9
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.终末期心力衰竭患者使用左心室辅助装置的临床疗效及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450.
10
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.

引用本文的文献

1
Effects of a remote patient monitoring program on cost of care for neonates with inadequate oral feeding.远程患者监测项目对经口喂养不足新生儿护理成本的影响。
J Perinatol. 2025 Jun 12. doi: 10.1038/s41372-025-02334-w.
2
Navigating the landscape of remote patient monitoring in Canada: trends, challenges, and future directions.探索加拿大远程患者监测的前景:趋势、挑战及未来方向。
Front Digit Health. 2025 Feb 4;7:1523401. doi: 10.3389/fdgth.2025.1523401. eCollection 2025.
3
ACGAN for Addressing the Security Challenges in IoT-Based Healthcare System.
基于 ACGAN 的物联网医疗系统安全挑战应对方案
Sensors (Basel). 2024 Oct 13;24(20):6601. doi: 10.3390/s24206601.
4
Introducing a Remote Patient Monitoring Usability Impact Model to Overcome Challenges.引入远程患者监测可用性影响模型以克服挑战。
Sensors (Basel). 2024 Jun 19;24(12):3977. doi: 10.3390/s24123977.
5
Challenges and Facilitators in Implementing Remote Patient Monitoring Programs in Primary Care.在基层医疗中实施远程患者监护项目的挑战和促进因素。
J Gen Intern Med. 2024 Oct;39(13):2471-2477. doi: 10.1007/s11606-023-08557-x. Epub 2024 Apr 23.
6
Satisfaction and use of the didactic simulator for learning the nursing process: an observational study.用于学习护理程序的教学模拟器的满意度及使用情况:一项观察性研究。
BMC Nurs. 2024 Jan 12;23(1):36. doi: 10.1186/s12912-024-01717-2.
7
Acceptability and feasibility of assisted telepsychiatry in routine healthcare settings in India: a qualitative study.印度常规医疗环境中辅助远程精神病学的可接受性和可行性:一项定性研究。
Oxf Open Digit Health. 2023 Oct 19;1:oqad016. doi: 10.1093/oodh/oqad016. eCollection 2023.
8
Rehabilitation Technologies for Chronic Conditions: Will We Sink or Swim?慢性病康复技术:我们会成功还是失败?
Healthcare (Basel). 2023 Oct 17;11(20):2751. doi: 10.3390/healthcare11202751.
9
Domains, Feasibility, Effectiveness, Cost, and Acceptability of Telehealth in Aging Care: Scoping Review of Systematic Reviews.远程医疗在老年护理中的领域、可行性、有效性、成本及可接受性:系统评价的范围综述
JMIR Aging. 2023 Apr 18;6:e40460. doi: 10.2196/40460.
10
Are we ready for telemonitoring inflammatory bowel disease? A review of advances, enablers, and barriers.我们是否已经准备好进行炎症性肠病的远程监测了?对进展、促成因素和障碍的回顾。
World J Gastroenterol. 2023 Feb 21;29(7):1139-1156. doi: 10.3748/wjg.v29.i7.1139.